Hawkins, Inc. enters its Q4 FY2026 earnings window — results due May 13 — with a notable cluster of insider selling behind it, options positioning turning more cautious, and short interest that has quietly retreated from March highs but remains a meaningful 6.3% of free float.
The most striking recent development is what happened on March 30. Five Hawkins insiders sold on the same day — President and CEO Patrick Hawkins, CFO Jeffrey Oldenkamp, and three vice presidents all liquidated shares at $151.62, collectively disposing of roughly $4.2 million in stock. The CEO's sale alone totalled just over $1.66 million across 10,950 shares. Net insider activity over the 90 days to March 30 was actually positive at roughly $4.6 million — a January director buy of around $389,000 across two tranches partially offsets the executive sales — but the concentration of selling at the C-suite level, just weeks before an earnings call, gives the setup a more cautious tone. The stock has since recovered to $164.57, well above the $151.62 sale price, which may reflect either the timing of the sales under a pre-planned programme or a market that has moved past the signal.
Short interest has pulled back from its March peak but has not collapsed. SI % FF hit roughly 7.6% in mid-March before fading through early April. The reading now stands near 6.3% of float, still elevated relative to a small-cap commodity chemicals name. Borrow conditions are loose. Cost to borrow is just 0.45%, barely changed over the past month. Availability is wide — roughly four shares available to borrow for every one currently shorted — which means there is no mechanical squeeze pressure in the lending market. The ORTEX short score of 54.9 places the name in a moderate short-interest percentile: notable, but not extreme. Days to cover per the most recent FINRA print is 7.2, meaning a meaningful but not catastrophic unwind would be needed to clear existing shorts. The week's 0.6% rise in short interest suggests some incremental rebuilding, but the 13% month-on-month decline in shares short is the more telling direction.
Options positioning has shifted more defensive this week. The put/call ratio jumped to 0.70 on April 29, nearly two standard deviations above its 20-day mean of 0.62. That is not a dramatic reading in absolute terms — the 52-week high sits at 1.41 — but the z-score of 1.93 marks one of the more cautious postures of recent months. It is consistent with hedging into a May 13 print rather than a structural change in sentiment. The stock's one-week gain of 0.5% tells a similar story: the market is broadly comfortable with HWKN at current levels but not pressing aggressively in either direction.
Analyst coverage is thin. BWS Financial has been the lone active voice, maintaining a Buy with a $200 target — a call that implies around 21% upside to the current price and was last reaffirmed in late March. Raymond James initiated at Market Perform in mid-2025 without a price target. With only two known active analysts and the mean price target from September 2025 at $166 (close to current levels), the Street is not a strong directional force here. Earnings momentum scores are more encouraging: the 30-day EPS momentum ranks in the 75th percentile, and the 12-month forward EPS estimate trend ranks in the 88th percentile. Those readings point to a business where estimates are drifting up, not down. The EV/EBITDA multiple of 18x has contracted about 1.6 turns over the past month. P/E stands near 37.9x — rich for a commodity chemicals name, though Hawkins has historically commanded a premium for its defensive water treatment business. Valuation is not obviously stretched relative to the past twelve months, but it is not cheap.
The earnings history amplifies the forward risk. Hawkins has delivered two consecutive large post-earnings swings: the February 2026 print saw the stock rally 8.3% on the day and 12.8% over five days; the January 2026 event — which may overlap in data with the same report — showed a 9% one-day drop and a 15.9% five-day loss. The October 2025 print was even sharper, with a 10.5% one-day fall and a 20% decline over the following week. That asymmetry — one strong positive versus two larger negative prints — reinforces the put-buying seen this week. Peers DD and FMC both fell on the week by roughly 3% and negligibly, respectively, while ASPI dropped sharply. Against that peer backdrop, HWKN's flat weekly performance looks relatively resilient.
What to watch into May 13: whether options hedging intensifies as the earnings date approaches, and whether short interest — currently drifting down from its March peak — begins to rebuild as the catalyst draws closer.
See the live data behind this article on ORTEX.
Open HWKN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
